PROJECT

Projects

Summary of Proposed Investment

Project Number

25947

Company Name

GRANULES INDIA LIMITED

Date SPI Disclosed

May 3, 2007

Country

India

Industry

Health, Education and Life Sciences

Projected Board Date

Jun 4, 2007

Status

Completed

Sector

Pharmaceuticals and Medicine

Department

Gbl Ind, Manufact, Agribus & Services

Environmental Category

B - Limited

Previous Events

Approved : Jun 7, 2007
Signed : Jun 8, 2007
Invested : Jun 14, 2007

Project Description

Granules India Limited (Granules or the company) is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to the bulk over-the-counter (OTC) drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants in India and one plant in China through a 50:50 joint venture (JV). The company is undertaking an investment program estimated to cost about $32 million, comprising of:

- setting up a 6 billion per annum multi-product tableting plant;
- setting up a 3,600 TPA paracetamol API plant;
- installing an additional 3,600TPA of paracetamol PFI capacity;
- investment in a JV in China for ibuprofen API with a capacity of 3,800TPA; and
- development and registration of new products.

Sponsor / Cost / Location

Development Impact